NCT02622568View on ClinicalTrials.gov

Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Verruca, Warts
Interventions
DRUG

Veregen only

Topical application of Veregen 15% ointment on affected areas twice daily

PROCEDURE

Cryotherapy and Veregen

Cryotherapy followed by topical application of Veregen 15% ointment on affected areas twice daily

Trial Locations (1)

75390-9069

UTSW Department of Dermatology, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02622568 - Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study | Biotech Hunter | Biotech Hunter